BETTERLIFE PHARMA INC. (BETRF) earnings per share
Annual history
Fiscal years 2013 – 2025
USD / SHARE 10 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-01-31 | -$0.03 | 2025-06-02 |
| FY 2024 | 2024-01-31 | -$0.03 | 2024-05-30 |
| FY 2023 | 2023-01-31 | -$0.10 | 2023-06-06 |
| FY 2022 | 2022-01-31 | -$0.16 | 2022-06-06 |
| FY 2021 | 2021-01-31 | -$1.34 | 2021-06-08 |
| FY 2020 | 2020-01-31 | -$1.30 | 2020-06-05 |
| FY 2019 | 2019-01-31 | -$1.03 | 2019-05-03 |
| FY 2016 | 2016-01-31 | -$1.10 | 2016-04-29 |
| FY 2015 | 2015-01-31 | -$0.11 | 2015-05-15 |
| FY 2013 | 2014-01-31 | -$0.20 | 2014-05-16 |
Quarterly history
Fiscal years 2015 – 2020
USD / SHARE 14 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2020 | 2019-04-30 | -$0.02 | 2019-06-17 |
| Q3 2019 | 2018-10-31 | -$0.40 | 2018-12-18 |
| Q1 2018 | 2018-04-30 | -$0.03 | 2018-06-19 |
| Q3 2018 | 2017-10-31 | $0.10 | 2017-12-15 |
| Q3 2019 | 2017-10-30 | $0.00 | 2018-12-18 |
| Q3 2017 | 2016-10-31 | -$0.10 | 2016-12-12 |
| Q1 2017 | 2016-04-30 | -$0.40 | 2016-06-14 |
| Q3 2016 | 2015-10-31 | $0.00 | 2015-12-15 |
| Q2 2016 | 2015-07-31 | -$0.04 | 2015-09-10 |
| Q1 2016 | 2015-04-30 | -$0.02 | 2015-06-17 |
| Q4 2015 | 2015-01-31 | -$0.11 | 2015-05-15 |
| Q3 2015 | 2014-10-31 | $0.00 | 2014-12-15 |
| Q2 2015 | 2014-07-31 | $0.00 | 2014-09-15 |
| Q1 2015 | 2014-04-30 | $0.01 | 2014-06-16 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2015).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
BETRF CIK 0001464165 Source: EDGAR filings · all facts